Immunic, Inc. (IMUX)
6.99
-0.40
(-5.41%)
USD |
NASDAQ |
Nov 20, 16:00
7.035
+0.04
(+0.64%)
Pre-Market: 20:00
Immunic Price to Book Value : 1.062 for Nov. 20, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.062 |
| November 19, 2026 | 1.123 |
| November 18, 2026 | 1.143 |
| November 17, 2026 | 1.114 |
| November 16, 2026 | 1.099 |
| November 13, 2026 | 1.143 |
| November 12, 2026 | 1.184 |
| November 11, 2026 | 1.234 |
| November 10, 2026 | 1.222 |
| November 09, 2026 | 1.21 |
| November 06, 2026 | 1.178 |
| November 05, 2026 | 1.113 |
| November 04, 2026 | 1.207 |
| November 03, 2026 | 1.155 |
| November 02, 2026 | 1.116 |
| October 30, 2026 | 1.142 |
| October 29, 2026 | 1.185 |
| October 28, 2026 | 1.213 |
| October 27, 2026 | 1.157 |
| October 26, 2026 | 1.107 |
| October 23, 2026 | 1.126 |
| October 22, 2026 | 1.098 |
| October 21, 2026 | 1.137 |
| October 20, 2026 | 1.126 |
| October 19, 2026 | 1.062 |
| Date | Value |
|---|---|
| October 16, 2026 | 1.060 |
| October 15, 2026 | 1.079 |
| October 14, 2026 | 1.012 |
| October 13, 2026 | 1.047 |
| October 12, 2026 | 1.208 |
| October 09, 2026 | 1.245 |
| October 08, 2026 | 1.149 |
| October 07, 2026 | 1.160 |
| October 06, 2026 | 1.189 |
| October 05, 2026 | 1.227 |
| October 02, 2026 | 1.21 |
| October 01, 2026 | 1.313 |
| September 30, 2026 | 1.414 |
| September 29, 2026 | 0.9529 |
| September 28, 2026 | 1.017 |
| September 25, 2026 | 0.9994 |
| September 24, 2026 | 0.9968 |
| September 23, 2026 | 1.002 |
| September 22, 2026 | 1.159 |
| September 21, 2026 | 1.158 |
| September 18, 2026 | 1.136 |
| September 17, 2026 | 1.107 |
| September 16, 2026 | 1.082 |
| September 15, 2026 | 1.109 |
| September 14, 2026 | 1.201 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.131 |
| Alnylam Pharmaceuticals, Inc. | 5.343 |
| Anika Therapeutics, Inc. | 1.288 |
| Savara, Inc. | 8.118 |
| Arrowhead Pharmaceuticals, Inc. | 116.18 |
Price to Book Value Related Metrics
| Price | 6.99 |
| Earnings Yield | -64.02% |
| Market Cap | 111.01M |